Literature DB >> 27470137

Diurnal glycemic fluctuation is associated with severity of coronary artery disease in prediabetic patients: Possible role of nitrotyrosine and glyceraldehyde-derived advanced glycation end products.

Makoto Watanabe1, Yasuyuki Kawai2, Michihiko Kitayama1, Hironubu Akao1, Atsushi Motoyama1, Minoru Wakasa1, Ryuhei Saito1, Hirofumi Aoki1, Kousuke Fujibayashi1, Taketsugu Tsuchiya1, Hiroaki Nakanishi3, Kazuyuki Saito3, Masayoshi Takeuchi4, Kouji Kajinami1.   

Abstract

BACKGROUND: Glucose fluctuation (GF) is a risk factor for coronary artery disease (CAD). However, it remains unknown whether specific indices of GF are risk factors for CAD. Therefore, we evaluated the relationship between GF, as determined by a continuous glucose monitoring system (CGMS) or the glucose level at 2h after a 75-g oral glucose tolerance test (75g OGTT 120), and the severity of CAD in prediabetic patients. We also evaluated whether nitrotyrosine (NT) and glyceraldehyde-derived advanced glycation end-products (Glycer-AGE) were induced by GF.
METHODS: Twenty-eight prediabetic patients underwent coronary angiography (CAG), and the Gensini score and the SYNTAX score were evaluated as the severity of CAD, while the mean amplitude of glycemic excursions (MAGE) by CGMS and 75g OGTT 120 were evaluated. Serum NT and Glycer-AGE were measured.
RESULTS: The MAGE was closely associated with the Gensini score (r=0.742, p<0.001) and the SYNTAX score (r=0.776, p<0.001), respectively. The 75g OGTT 120 was not associated with the Gensini score (r=0.36, p=0.06), but it was significantly associated with the SYNTAX score (r=0.413, p=0.036). Multiple linear regression analysis showed that the MAGE was the only independent determinant for the severity of CAD. The levels of NT and Glycer-AGE were significantly higher in the high MAGE group than in the low MAGE group.
CONCLUSIONS: Diurnal GF is associated with the severity of CAD, even in prediabetic patients. GF, NT, and Glycer-AGE may play a pathological role in the progression of CAD.
Copyright © 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Glucose fluctuation; Glyceraldehyde-derived advanced glycation end-products; Nitrotyrosine

Mesh:

Substances:

Year:  2016        PMID: 27470137     DOI: 10.1016/j.jjcc.2016.07.001

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  12 in total

Review 1.  Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyle.

Authors:  Masayoshi Takeuchi
Journal:  Diabetol Metab Syndr       Date:  2020-11-30       Impact factor: 3.320

Review 2.  Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD.

Authors:  Masayoshi Takeuchi; Jun-Ichi Takino; Akiko Sakasai-Sakai; Takanobu Takata; Mikihiro Tsutsumi
Journal:  Nutrients       Date:  2017-06-20       Impact factor: 5.717

3.  Two-hour post-challenge hyperglycemia, but not fasting plasma glucose, associated with severity of coronary artery disease in patients with angina.

Authors:  Chia-Po Fu; Wayne H-H Sheu; Wen-Lieng Lee; Wen-Jane Lee; Jun-Sing Wang; Shih-Yi Lin; I-Te Lee
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

4.  Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease.

Authors:  Takanobu Takata; Akiko Sakasai-Sakai; Tadashi Ueda; Masayoshi Takeuchi
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

Review 5.  Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease.

Authors:  Raphael S Pinto; Carlos A Minanni; Aécio Lopes de Araújo Lira; Marisa Passarelli
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

6.  Effectiveness of Early Advanced Glycation End Product Accumulation Testing in the Diagnosis of Diabetes: A Health Risk Factor Analysis Using the Body Mass Index as a Moderator.

Authors:  Yi Zhang; Tian Jiang; Chao Liu; Honglin Hu; Fang Dai; Li Xia; Qiu Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-11       Impact factor: 5.555

7.  Advanced glycation end products and diabetes and other metabolic indicators.

Authors:  Tian Jiang; Yi Zhang; Fang Dai; Chao Liu; Honglin Hu; Qiu Zhang
Journal:  Diabetol Metab Syndr       Date:  2022-07-25       Impact factor: 5.395

8.  Impact of daily glucose fluctuations on cardiovascular outcomes after percutaneous coronary intervention for patients with stable coronary artery disease undergoing lipid-lowering therapy.

Authors:  Hiroyuki Yamamoto; Toshiro Shinke; Hiromasa Otake; Hiroyuki Kawamori; Takayoshi Toba; Masaru Kuroda; Yushi Hirota; Kazuhiko Sakaguchi; Wataru Ogawa; Ken-Ichi Hirata
Journal:  J Diabetes Investig       Date:  2020-12-18       Impact factor: 4.232

9.  Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study.

Authors:  Run Du; Rui Yan Zhang; Lin Lu; Ying Shen; Li Jin Pu; Zheng Bin Zhu; Qi Zhang; Jian Hu; Zhen Kun Yang; Feng Hua Ding; Jian Sheng Zhang; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-11-27       Impact factor: 9.951

Review 10.  Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage.

Authors:  Masayoshi Takeuchi; Akiko Sakasai-Sakai; Takanobu Takata; Jun-Ichi Takino; Yoshiki Koriyama; Chigusa Kikuchi; Ayako Furukawa; Kentaro Nagamine; Takamitsu Hori; Tamihide Matsunaga
Journal:  Biomolecules       Date:  2021-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.